Functional Biological Activity of Sorafenib as a Tumor-Treating Field Sensitizer for Glioblastoma Therapy

Glioblastoma, the most common primary brain tumor in adults, is an incurable malignancy with poor short-term survival and is typically treated with radiotherapy along with temozolomide. While the development of tumor-treating fields (TTFields), electric fields with alternating low and intermediate i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jo, Yunhui, Kim, Eun Ho, Sai, Sei, Kim, Jin Su, Cho, Jae-Min, Kim, Hyeongi, Baek, Jeong-Hwa, Kim, Jeong-Yub, Hwang, Sang-Gu, Yoon, Myonggeun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274791/
https://www.ncbi.nlm.nih.gov/pubmed/30469352
http://dx.doi.org/10.3390/ijms19113684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274791/
https://www.ncbi.nlm.nih.gov/pubmed/30469352
http://dx.doi.org/10.3390/ijms19113684

Ejemplares similares